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Abstract
Background: Claims data provide rapid indicators of SSIs for coronary artery bypass surgery and
have been shown to successfully rank hospitals by SSI rates. We now operationalize this method
for use by payers without transfer of protected health information, or any insurer data, to external
analytic centers.
Results: We performed a descriptive study testing the operationalization of software for payers
to routinely assess surgical infection rates among hospitals where enrollees receive cardiac
procedures. We developed five SAS programs and a user manual for direct use by health plans and
payers. The manual and programs were refined following provision to two national insurers who
applied the programs to claims databases, following instructions on data preparation, data
validation, analysis, and verification and interpretation of program output.
A final set of programs and user manual successfully guided health plan programmer analysts to
apply SSI algorithms to claims databases. Validation steps identified common problems such as
incomplete preparation of data, missing data, insufficient sample size, and other issues that might
result in program failure. Several user prompts enabled health plans to select time windows, strata
such as insurance type, and the threshold number of procedures performed by a hospital before
inclusion in regression models assessing relative SSI rates among hospitals. No health plan data was
transferred to outside entities.
Programs, on default settings, provided descriptive tables of SSI indicators stratified by hospital,
insurer type, SSI indicator (inpatient, outpatient, antibiotic), and six-month period. Regression
models provided rankings of hospital SSI indicator rates by quartiles, adjusted for comorbidities.
Programs are publicly available without charge.
Conclusion: We describe a free, user-friendly software package that enables payers to routinely
assess and identify hospitals with potentially high SSI rates complicating cardiac procedures.
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Background
Surgical site infections (SSIs) are among the most com-
mon healthcare-associated infections [1], and they incur
substantial morbidity and mortality. Monitoring and
feedback of SSI rates has consistently resulted in improve-
ment of SSI rates when combined with other quality
improvement activities [2]. Recently, increased emphasis
has been placed on SSI rates as a quality indicator for hos-
pitals, and some state legislatures are requiring hospitals
to report SSI rates as part of report cards intended for pub-
lic use in comparing hospitals to one another (Illinois
Public Act 93-0563; Missouri HCS/SS/SCS/SB 1279 - Mis-
souri Nosocomial Infection Control Act of 2004).
The ability of hospitals to monitor SSI rates is limited by
three factors. First, current surveillance methods are so
resource-intensive that many hospitals are able to moni-
tor only selected procedures. Second, current surveillance
definitions include subjective components, such as a sur-
geon's diagnosis of SSI, which create the opportunity for
substantial variation in judgment and documentation.
Third, a majority of SSIs occur days or weeks after hospital
discharge and elude hospital-based tracking systems [3,4].
Attempts to use patient and surgeon self-reporting via
questionnaires or phone calls to identify post-discharge
infections are both insensitive and resource-intensive [4-
7].
These limitations to conventional surveillance for SSI
have prompted the development of surveillance methods
based upon automated data that are routinely collected
during the delivery of, or payment for, healthcare. Previ-
ous work by this group has demonstrated the ability of
automated hospital-based pharmacy data and discharge
diagnoses codes to significantly improve detection of pre-
discharge SSIs [8-11].
Beyond pre-discharge assessment of SSIs, health plans and
payers possess automated data on the full breadth of
claims for hospitalizations, outpatient visits, antibiotic
utilization, and diagnosis codes. This enables automated
and comprehensive identification of indicators of infec-
tion following a specific type of surgery, regardless of
whether care is sought at the same hospital at which the
procedure was initially performed [16,17]. An additional
benefit is that claims data are largely standardized across
medical facilities and providers, enabling a potentially
universal method for detection of SSI indicators.
We have previously shown that administrative claims data
can identify pre- and post-discharge SSIs [12-16]. The pur-
pose of this prior work was not to measure actual SSI rates
in individual hospitals, but rather to be able to relatively
rank hospitals by SSI rates to identify potential outliers.
Claims-based algorithms were designed to be highly sen-
sitive, but less specific in detecting actual SSIs. Thus,
claims-based indicator rates were higher than the actual
SSI rates, but nevertheless, were successfully able to rank
hospitals by quartiles of SSI rates.
In particular, a claims-based algorithm for identifying SSIs
after coronary artery bypass graft surgery (CABG) was val-
idated in several health insurers by extensive medical
record review [16]. This algorithm was shown to success-
fully identify post-surgical infections and provide qualita-
tive rankings of hospitals by SSI rates after adjustment for
age, sex, and comorbidities. Furthermore, comparisons of
hospitals were also possible using merged data from mul-
tiple payer sources.
Importantly, prior work evaluating these algorithms nec-
essarily required the release of health insurer data, includ-
ing protected health information, to an external academic
center for analysis and refinement of the algorithms. In a
time where protection of identifiable health information
is critically important, the utility of such algorithms
depends, in part, on their potential to be used at the payer
location by payer-specific programmers and analysts. Our
goal was to develop user-friendly software for routine
serial use by healthcare insurers to assess relative SSI rates
at hospitals performing procedures on their enrollees.
This software could be used to track a hospital's relative
performance over time, provide information to members
in need of surgery, and, ultimately, reduce payer costs by
preferring hospitals with relatively low SSI rates for a given
procedure.
The purpose of this study was not to re-validate the
claims-based algorithms for detecting post-CABG SSIs,
but rather to demonstrate that these algorithms could be
operationalized into a user-friendly software package for
use at the payer level without transfer of claims data to an
external analysis center. We now describe a method, and
provide accompanying computer programs, to allow the
payers to routinely use this approach to identify hospitals
that may have high rates of SSIs complicating cardiac pro-
cedures.
Implementation
Technical details for preparing data inputs and applying
the software to claims data are provided in the online user
manual [20]. This manual and the associated software are
publicly available without charge.
Results
Description of Application Package
We developed an application that accepts inputs in the
form of claims data for patients undergoing cardiac proce-
dures and returns aggregated hospital-specific rates of SSI
indicators. The application consists of an instruction set,BMC Medical Research Methodology 2007, 7:20 http://www.biomedcentral.com/1471-2288/7/20
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data dictionary, and a series of five SAS programs (SAS
Institute, Cary, NC). In brief, a user manual guides health
plan analysts through the steps to format common claims
codes into data inputs needed for the application package.
Analysts extract claims for patients with cardiac proce-
dures identified by ICD9 codes, and create five files using
data layouts that are provided: a surgery file, membership
file, demographic file, dispensing file, and inpatient/out-
patient utilization file. The programs create patient-level
analysis files that combine demographic, inpatient, out-
patient, and pharmacy dispensing data to identify patients
who have an indicator (e.g. diagnosis or procedure or
antibiotic dispensing) suggesting a postoperative infec-
tion. It then aggregates this information by the hospital at
which the procedure was performed, and ranks hospitals
according to the fraction of patients with an indicator of
infection. The rankings are case-mix adjusted for the
patients' age, sex, and comorbidity, assessed by the
chronic disease score [18,19]. This study was approved by
the institutional review board of Harvard Pilgrim Health
Care.
Patient-level files
The surgery file identifies cardiac procedures based upon
ICD9 codes related to invasive cardiac surgery (36.10–
36.19, 36.2) and non-invasive cardiac procedures (35.00–
35.04, 35.96, 36.01–36.07, 36.09, 35.10–35.14, 35.20–
35.28, 35.33, 39.61, 39.66), along with facility, date of
procedure, dates of admission and discharge, discharge
status, and type of health plan membership (programs
select the two most populous groups, e.g. Medicare, com-
mercial, but user override exists) at the time of the proce-
dure. The membership file includes dates of health plan
enrollment, and an indicator of whether or not the mem-
ber had pharmacy coverage. The demographic file
includes gender, date of birth, and the type of health plan
coverage (e.g. Medicare or commercial). The dispensing
file includes the date, amount, and type of all covered
medications dispensed in the ambulatory setting for the
period of 182 days prior to the procedure date through 30
days afterward. Finally, the utilization file includes all
inpatient and outpatient claims occurring from the admit
date associated with the procedure of interest to 30 days
afterward. All procedure episodes are linked within the
five files by the member's identification number.
Creation of hospital-level performance measures
The application creates hospital-level aggregate data as
follows:
Episodes of cardiac procedures are identified and then cat-
egorized as having outpatient pharmacy benefits or not.
Pharmacy coverage is judged to be in effect for the peri-
operative period if a) any dispensings occur during the six
months (182 days) preceding the operation, b) any dis-
pensings occur during the 30 days following the opera-
tion, or c) membership information indicates post-
operative pharmacy coverage. This approach is technically
simpler than assessing the individuals' pharmacy benefits
coverage status during this 212 day period; in our experi-
ence the correlation between prescription dispensings and
pharmacy coverage has been sufficient for this purpose. If
at least 80% of episodes are performed in members with
pharmacy coverage, then default analyses are restricted to
those members with pharmacy benefits, thus enabling the
addition of outpatient antibiotic prescriptions as an SSI
indicator. If fewer than 80% of patients have pharmacy
coverage, then outpatient antibiotic exposure is ignored
for all patients, and no patients are ignored because of
lack of pharmacy coverage. Inclusion of pharmacy benefit
information is preferred, in part because it permits partial
adjustment for hospitals' case-mix via a chronic disease
score based on the six months of pharmacy dispensing
prior to the cardiac procedure [18,19].
These cardiac procedure episodes are assigned sex, gender,
insurer type (e.g. Medicare versus commercial), and a
chronic disease score (Clark TC score) based on member
information [18,19]. Each cardiac procedure episode is
then evaluated for the occurrence of SSI indicators within
30 days following the procedure [16]. Inpatient SSI indi-
cators are based upon diagnosis or procedure codes sug-
gestive of infection during either the index admission or a
hospital re-admission. Outpatient SSI indicators are based
upon diagnosis or procedure codes suggestive of infection
during either an emergency department visit or an outpa-
tient provider visit. In addition, if available, pharmacy
claims for anti-staphylococcal antibiotics within 30 days
of the procedure result in an outpatient SSI indicator for
antibiotic usage. These SSI indicators are aggregated by
type for each hospital that performs the cardiac proce-
dures of interest.
Prior to any aggregation of data or descriptive output,
health plan analysts are directed to a series of prompts to
define user options. Available user options are found in
Table 1.
Data Integrity
The program runs a series of validation steps to routines
to assist payer-based analysts in identifying common
problems, such as incomplete or incorrectly formatted
input files that either prevent the programs from running
or yield incorrect results. For example, steps direct the user
to evaluate whether procedure dates span the entire spec-
ified date range, whether the number of procedures is sim-
ilar across the time window, whether any procedure codes
fail to identify any procedures, and whether any other var-
iables or strata generate a zero count. Additional guidance
is provided in the user guide [20] to help quality assuranceBMC Medical Research Methodology 2007, 7:20 http://www.biomedcentral.com/1471-2288/7/20
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analysts determine whether the data are likely to be com-
plete.
Data Analyses
The programs create summary tables describing the over-
all number of total, invasive, and non-invasive cardiac
procedures and the percentage with at least one SSI indi-
cator by half-year. SSI indicator rates are further stratified
by insurer type and type of indicator, e.g. inpatient indica-
tor versus outpatient indicator.
The programs additionally create detailed tables display-
ing hospital-specific descriptive data (age, gender, chronic
disease score) and hospital-specific numbers of total,
invasive, and non-invasive cardiac procedures. Hospitals
are ranked by their specific SSI indicator rates, and are fur-
ther grouped into quartiles. Furthermore, SSI indicators
are stratified by insurer type, cardiac procedure type (e.g.
total, invasive, non-invasive), indicator type (e.g. total,
inpatient, emergency department, ambulatory care, anti-
biotic), and half-year.
A previously validated multivariate logistic regression
model [16] assesses the risk of SSI indicators using
patient-level inputs including gender, chronic disease
score ≥ 4,500, [21] type of insurer plan (e.g. Medicare ver-
sus commercial), and hospital in which the cardiac proce-
dure was performed. The hospital covariate is entered as a
categorical variable of hospitals performing >40 cardiac
procedures across the selected period of interest. The
default threshold of 40 procedures was selected to avoid
unstable estimates; however, this threshold can be
changed by the user. The model assesses the relative odds
of infection conferred by a given hospital in comparison
to the risk of infection among all patients having proce-
dures in hospitals with unadjusted SSI indicator rates in
the lowest quartile. The adjusted odds ratio for each hos-
pital covariate can then be compared against unadjusted
rankings.
Among top quartile hospitals with at least 40 procedures,
the program provides a line list of procedures that have at
least one associated SSI indicator. Individual membership
information is provided along with procedure date, proce-
dure location, procedure code and text, and associated SSI
indicators by type, date, location, and claims code and
text.
Testing of Application Package
We worked with health plans affiliated with UnitedHealth
Group (UHG) [22] and Humana Incorporated to develop
and test these programs. After a few iterations involving
data validation steps such reformatting of pharmacy
inputs, algorithms ran successfully. These attempts ena-
bled us to consider and provide comprehensive data vali-
dation routines.
The application package was tested using a slightly earlier
version than the one released with this publication. In
particular, it involved small differences in ICD-9 codes for
both invasive (35.10–35.14, 35.20–35.28, 35.33, 36.10–
36.19, 36.2) and non-invasive (35.00–35.04, 35.96,
36.01–36.07, 36.09) cardiac procedures. It was applied to
5,878 cardiac procedures in UHG members performed
between January 1, 1996 and December 31, 2001, and to
1,106 cardiac procedures in Humana members performed
between January 1, 2003 and June 30, 2003.
Selected output from the application is provided here as
an example of the type of results generated under default
settings. Table 2 provides cohort descriptions of health
plan members undergoing cardiac procedures from the
two health plans. Table 3 details the frequency of SSI indi-
cators among these procedures.
Cardiac procedures among UHG members were per-
formed in 104 hospitals. The number of procedures per
hospital ranged from 1 to 273. Overall, 7.1% (413/5,787)
of procedures were associated with 457 SSI indicators. The
majority of indicators occurred post-discharge in the out-
patient setting. Among Humana members, 8.7% (96/
1,106) of procedures were associated with SSI indicators.
The distribution of infection indicator types was provided
as standard output, with selected types shown in Table 2.
Table 1: User Options
Option Default
1. Time window of Interest None
2. Maximum number of diagnoses in any single claims record 4
3. Maximum number of procedures in a single claims record 5
4. Definition of two most common plan types None
5. Acceptable membership gap * 45
6. Threshold % of patients with prescription activity to restrict analyses to those with prescription benefits ≥ 80%
7. Threshold number of cardiac procedures during the time window for a hospital's inclusion in multivariate analyses 40
8. Quartile of hospital SSI rates for detailed patient output 4th
* Brief lapses in enrollment during the time window which do not result in exclusionBMC Medical Research Methodology 2007, 7:20 http://www.biomedcentral.com/1471-2288/7/20
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Although the proportion of cardiac procedures with an
inpatient SSI indicator appears to be substantially higher
among Humana members compared to UHG members,
they are not comparable across the payers since different
claims processes result in differing detection rates of
claims-based SSI indicators. We focus here on the qualita-
tive ranking of hospitals by SSI indicator rates provided by
these algorithms for claims data within a payer system.
Prior work has shown that payer data can be successfully
combined to yield accurate relative SSI rates among hos-
pitals when adjusting for the payer [16].
Qualitative ranking of hospitals by SSI indicator rates
were successfully performed by the provided programs
using data from each health plan. We provide additional
UHG results as an example of selected output. Among the
subgroup of 44 hospitals with claims for ≥ 40 cardiac pro-
cedures in UHG members, the percentage of unadjusted
SSI indicators ranged from 1.5 to 18.9%. The lowest quar-
tile of hospitals' SSI indicator rates ranged from 1.5–4.4%
(median 3.5%), and the highest quartile ranged from 9.8–
18.9% (median 12.5%). Inpatient infection indicators
ranged from 0% across the entire lowest quartile to 3.7–
9.5% (median 5.0%) among the highest quartile, while
outpatient infection indicators ranged from 0–3.5%
(median 2.8%) in the lowest quartile and 7.1–13.5%
(median 9.7%) in the highest quartile. These rates repre-
sent SSI indicators among both invasive and non-invasive
procedures combined; however, the programs also pro-
vide stratification by procedure type.
When evaluating the multivariate models providing
adjusted ranking of hospitals by the percentage of cardiac
procedures among UHG members with any SSI indicator,
we found that, in this dataset, adjusted and unadjusted
results were similar in the highest quartile of SSI rates (Fig-
ure 1). Algorithms provided odds ratio estimates for all
quartiles in comparison to the 1st  quartile (data not
shown). In addition, the UHG data showed that Medicare
insurer type (OR = 1.4, CI: 1.0, 1.8) and a chronic disease
score ≥ 4,500 (OR = 2.0, CI: 1.3, 3.3) were also signifi-
cantly associated with having an infection indicator
within the 30-day period following the procedure. Male
gender was not predictive of an SSI indicator.
Discussion
We previously developed and validated an automated
method of using health plan claims data to identify surgi-
cal site infections following cardiac procedures [13,16].
We now show that this method can be operationalized for
use at the payer-level, without the need for transfer of pro-
tected health information to an external analytic center.
This capability and provision of a user manual, SAS pro-
grams, test datasets, and sample output for public use,
enables payers to use this software to routinely and seri-
ally assess post-cardiac SSI rates among hospitals fre-
Table 2: Characteristics of Health Plan Members Undergoing Cardiac Procedures
UnitedHealth Group Humana Inc.
Time Period 1-1-96 to 12-31-01 1-1-03 to 6-30-03
Cardiac Procedures (N) 5,787 1,106
Mean Age at Procedure 61.2 years 68.7 years
% Male 72% 66%
Mean Chronic Disease Score 1,708 3,372
Insurer Plan
% Medicare 1,852 (32%) 757 (68%)
% Commercial 3,935 (68%) 349 (32%)
Hospitals (N) 104 10
Table 3: Surgical Site Infection Indicators Following Cardiac Procedures
UnitedHealth Group Humana Inc.
Total Procedures 5,787 1,106
Any Infection Indicator N (%) 413 (7.1%) 96 (8.7%)
Inpatient Infection Indicator N (%) 153 (2.6%) 73 (6.6%)
Pre-Discharge N (%) 66 (1.1%) 42 (3.8%)
Post-Discharge with Readmission N (%) 90 (1.6%) 51 (4.6%)
Outpatient Infection Indicator N (%) 304 (5.3%) 60 (5.4%)
Antibiotic Indicator N (%) 73 (1.3%) N/A*
Ambulatory Diagnosis N (%) 199 (3.4%) 34 (3.1%)
Emergency Dept Diagnosis N (%) 41 (0.7%) 39 (3.5%)
* Post-procedure antibiotic dispensing data not availableBMC Medical Research Methodology 2007, 7:20 http://www.biomedcentral.com/1471-2288/7/20
Page 6 of 7
(page number not for citation purposes)
quented by their enrollees. These programs are available
without charge [20].
These programs can be applied periodically, e.g., every six
or twelve months, to identify hospitals that may warrant
closer attention, to assess secular trends, to evaluate the
impact of healthcare or health plan polices on SSI indica-
tor rates, or to screen for improvement in specific hospi-
tals previously identified as having potentially high
infection rates. After adjusting for health plan, the aggre-
gated data can be combined across plans/payers to pro-
vide more precise estimates when a hospital's procedures
are spread across several payers, [16] although this capa-
bility is not provided in this software version.
The use of SSI indicators based on claims data has several
advantages over traditional surveillance. It uses readily
available data, requires relatively small investment of
resources to maintain after the programs have been con-
figured to operate in a specific claims environment, and is
less susceptible to subjective interpretations compared
with conventional infection surveillance. In principle, this
type of surveillance can be applied to the large majority of
institutions that perform cardiac procedures in the United
States.
Additionally this approach can identify SSI indicators that
occur in the post-discharge setting. It enables identifica-
tion of SSI indicators resulting in re-hospitalization, even
in institutions other than the ones that performed the
original procedure; at present, hospitals are rarely able to
track these events. It also identifies outpatient infection
indicators based upon clinic visits, emergency department
visits, and antibiotic prescriptions. The ability to distin-
guish outpatient from inpatient infection indicators pro-
vides further insight into the sources of elevated SSI rates.
This is a valuable component of SSI surveillance since
post-discharge SSIs are known to constitute the majority
of infections, although there is no agreed upon method to
identify them.
There are several important caveats in using these pro-
grams. First, these indicators are only surrogates for con-
firmed surgical site infections. Although they have been
shown to correlate reasonably well with actual SSI rates at
the level of hospitals in prior validation studies, we
believe they are most appropriately used at this time to
identify hospitals that bear closer scrutiny to determine
whether their SSI rates really are high. For that reason, we
have configured the programs to focus attention on the
hospitals in the top quartile. Although these SSI indicators
have been validated as important surrogates for SSI
rates,[16] we believe that further validation is needed
across additional health plans and that these SSI indicator
rates should not be directly equated with actual SSI rates.
Second, a substantial amount of the variation between
hospital SSI indicator rates (and confirmed SSI rates) is
probably caused by variation in case-mix that may not
corrected by the factors available in claims data. It will be
important to avoid using these rates for inter-hospital
comparisons without further accounting for this variation
in case-mix. Third, due to the instability of rankings when
small numbers are used, these programs suggest that only
hospitals performing a minimum number of annual car-
diac procedures (default = 100) be assessed. While this
threshold number can be changed at the user's discretion,
in general, this methodology is unable to meaningfully
comment on hospitals performing a very small number of
procedures. Decisions on how to adequately assess these
hospitals during a time of national standards and public
reporting are needed, but beyond the scope of this paper.
Finally, these SSI indicator rates are unlikely to be useful
in comparing individual surgeons. Problems of case-mix
and small sample size are greatly magnified at the level of
individual surgeons.
Although these algorithms have been previously validated
and are now operationalized for US health payers, they
could be modified for use in other countries by finding
corresponding claims codes. Nevertheless, given the lack
of prior validation in non-US health systems, the selection
of corresponding codes and the demonstration that the
Claims-based Indicators of Surgical Site Infection Figure 1
Claims-based Indicators of Surgical Site Infection. 
Graphical display of the hospitals serving UnitedHealth 
Group members which are in the top quartile of percentage 
surgical site infection indicators following a cardiac proce-
dure. Hospitals are ranked by their odds ratio compared to a 
hypothetical control hospital with the median percentage of 
SSI indicators from among the lowest quartile of hospitals. 
Odds ratios were derived from a multivariate model control-
ling for insurer type, sex, chronic disease score, and epoch 
(see text). Unadjusted percentages of SSI indicators are also 
shown for each hospital.BMC Medical Research Methodology 2007, 7:20 http://www.biomedcentral.com/1471-2288/7/20
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algorithm applies to non-US medical care would be
needed.
Conclusion
This simplified screening tool based on readily available
claims data offers insurers the potential of rapid, periodic,
and comprehensive assessments comparing indicators for
SSIs across hospitals performing cardiac procedures.
Compared to subjective and labor-intensive chart reviews,
this methodology applies uniform criteria for SSI indica-
tors and is not limited to the initial hospital stay in which
the procedure occurred. Payors can thus identify hospitals
with potentially high SSI rates and target further evalua-
tions.
Availability and Requirements
The programs, test datasets, and user manual are publicly
available for downloading at http://cardiac.ssi.chip.org.
Programs require SAS version 9.0 (Cary, NC) or above and
will run on any SAS platform.
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